Literature DB >> 15507450

Myocardial ischemia differentially regulates LKB1 and an alternate 5'-AMP-activated protein kinase kinase.

Judith Y Altarejos1, Masayuki Taniguchi, Alexander S Clanachan, Gary D Lopaschuk.   

Abstract

During myocardial ischemia, activation of 5'-AMP-activated protein kinase (AMPK) leads to the stimulation of glycolysis and fatty acid oxidation. Together these metabolic changes contribute to cardiac dysfunction. Although AMPK signaling in the ischemic heart is well characterized, the relative contribution of phosphorylation by AMPK kinase (AMPKK), and positive allosterism by the ratios of AMP:ATP and creatine (Cr):phosphocreatine (PCr), in stimulating AMPK during ischemia are unknown. In hearts subjected to severe ischemia, the ratios of AMP:ATP and Cr:PCr were significantly elevated as compared with aerobic hearts. Severe ischemia stimulated AMPK signaling, as demonstrated by an increase in both AMPK activity and acetyl-CoA carboxylase phosphorylation. Although AMPK phosphorylation was increased by severe ischemia, the protein abundance and activity of the recently identified AMPKK, LKB1, were similar between aerobic and severely ischemic hearts. However, in contrast to LKB1, the activity of AMPKK was stimulated in severely ischemic hearts. To further delineate the relative roles of positive allosterism and AMPKK in the regulation of AMPK during ischemia, hearts were subjected to mild ischemia. Although mild ischemia did not alter the ratios of AMP:ATP and Cr:PCr, mild ischemia increased AMPK activity and increased AMPK phosphorylation. Mild ischemia also stimulated the activity of AMPKK. In summary, we demonstrate that myocardial ischemia stimulates AMPK via an AMPKK other than LKB1. Additionally, we show that changes in high energy phosphates are not essential for the activation of AMPK by ischemia. Our data emphasize the critical role AMPKK plays in mediating AMPK signaling during myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507450     DOI: 10.1074/jbc.M411810200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases.

Authors:  Michela Capano; Martin Crompton
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

2.  Neuronal protein tyrosine phosphatase 1B deficiency results in inhibition of hypothalamic AMPK and isoform-specific activation of AMPK in peripheral tissues.

Authors:  Bingzhong Xue; Thomas Pulinilkunnil; Incoronata Murano; Kendra K Bence; Huamei He; Yasuhiko Minokoshi; Kenji Asakura; Anna Lee; Fawaz Haj; Noboru Furukawa; Karyn J Catalano; Mirela Delibegovic; James A Balschi; Saverio Cinti; Benjamin G Neel; Barbara B Kahn
Journal:  Mol Cell Biol       Date:  2009-06-15       Impact factor: 4.272

Review 3.  Regulation of AMPK by the ubiquitin proteasome system.

Authors:  Makhosazane Zungu; Jonathan C Schisler; M Faadiel Essop; Chris McCudden; Cam Patterson; Monte S Willis
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

4.  AMP-activated protein kinase connects cellular energy metabolism to KATP channel function.

Authors:  Hidetada Yoshida; Li Bao; Eirini Kefaloyianni; Eylem Taskin; Uzoma Okorie; Miyoun Hong; Piyali Dhar-Chowdhury; Michiyo Kaneko; William A Coetzee
Journal:  J Mol Cell Cardiol       Date:  2011-08-24       Impact factor: 5.000

Review 5.  Potential beneficial mechanisms of insulin (glucose-potassium) in acute myocardial infarction.

Authors:  I C C van der Horst; F Zijlstra
Journal:  Neth Heart J       Date:  2005-06       Impact factor: 2.380

Review 6.  AMPK alterations in cardiac physiology and pathology: enemy or ally?

Authors:  Jason R B Dyck; Gary D Lopaschuk
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

7.  Adiponectin downregulation is associated with volume overload-induced myocyte dysfunction in rats.

Authors:  Li-li Wang; Dori Miller; Desiree Wanders; Gayani Nanayakkara; Rajesh Amin; Robert Judd; Edward E Morrison; Ju-ming Zhong
Journal:  Acta Pharmacol Sin       Date:  2015-11-30       Impact factor: 6.150

8.  AMP-dependent protein kinase activators: not just for diabetes?

Authors:  Heberty T F Facundo; Steven P Jones
Journal:  Circ Res       Date:  2009-02-13       Impact factor: 17.367

9.  The activation of AMPK in cardiomyocytes at the very early stage of hypoxia relies on an adenine nucleotide-independent mechanism.

Authors:  Hong Yan; Dongxia Zhang; Qiong Zhang; Pei Wang; Yuesheng Huang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

10.  Copper deficiency results in AMP-activated protein kinase activation and acetylCoA carboxylase phosphorylation in rat cerebellum.

Authors:  Anna A Gybina; Joseph R Prohaska
Journal:  Brain Res       Date:  2008-02-13       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.